Improving the Follow-up of Diabetic Patients by Measuring Earwax Glucose Concentration through a Self-Sampling Device

trears生物标志物的使命是改善可持续诊断的可及性。Trears是一种专利诊断设备，可用于非侵入性检测糖尿病。解析：句意：据估计，世界上有4.15亿人患有糖尿病，占世界成年人口的1 / 11。糖尿病患者对糖尿病检测的依从率非常低。研究发现，先前住院的糖尿病患者中有51%的人在住院后拒绝参加门诊随访会议。1979) __。这组患者的再入院率明显高于可能随访的患者。我们发现，在估计一个月内慢性血糖时，Trears耳垢葡萄糖的可预测性比HbA1c高59%。Trears测试具有成本效益，无痛，准确和可靠（H__erane-Vives, a . et al 2021）。该项目将是完成监管提交以实现商业化的关键一步。[4] [j] .一种新型的耳垢自采样装置：可行性研究。应用科学，2013 - - -中国耳垢科学杂志。自然科学，2021,11(11),4882；[qh]王晓东，王晓东，王晓东，等。教育糖尿病患者：后续会议的经验。《糖尿病护理》1979；2:35-38 \。_ [0]: https://doi.org/10.3390/app11114882

_Trears biomarkers is on a mission to improve access to sustainable diagnostics. Trears is a patented diagnostic device, which can be used to non-invasively detect diabetes.__It is estimated that 415 million people are living with diabetes in the world, which is estimated to be 1 in 11 of the world's adult population. Adherence rates to diabetes testing among diabetes patients are very low. It has been found that up 51% of the diabetes patients, who were previously hospitalised declined an invitation to attend outpatient follow-up sessions after hospitalization_ _(Whitehouse FW et at. 1979)__. This group of patients had significantly higher hospital readmission rates than patients who were possible to follow up.__We found that Trears earwax glucose is 59% more predictable that HbA1c for estimating chronic glycaemia over a month. Trears test is cost effective, pain free, accurate and reliable (H__erane-Vives, A. et al 2021)__This project will be a critical step towards completion of the regulatory submission to enable commercialisation.__Herane-Vives, A. et al A Novel Earwax Self Sampling Device: A Feasibility Study Applied Sciences, 2021 - mdpi.com Appl. Sci. 2021, 11(11), 4882;_ _[https://doi.org/10.3390/app11114882][0]__Whitehouse FW, Whitehouse IJ, Smith J, et al. Teaching the person with diabetes: experience with a follow-up session. Diabetes Care. 1979; 2:35-38\._[0]: https://doi.org/10.3390/app11114882